Search results
Pfizer Inc.’s latest rating changes from various analysts – Knox Daily
Knox Daily· 4 days agoPfizer Inc.’s recently made public that its Director Gottlieb Scott acquired Company’s shares for reported $79401.0 on Dec 15 ’23. In the deal valued at $26.47 per share,3,000 ...
1 Top Dividend Stock to Load Up On Now
Motley Fool via Yahoo Finance· 2 days agoThey are the bedrock of a portfolio designed for the long haul, offering a balance of stability and growth potential. One healthcare giant stands out In...
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
Benzinga· 4 days agoA Delaware federal jury has determined that AstraZeneca Plc AZN must pay Pfizer Inc PFE $107.5...
Grey Wolf gains $50m boost for antigen modulation tech
Pharmaceutical Technology via Yahoo Finance· 6 hours agoICG's Life Sciences team spearheaded the Series B expansion, with support from current investors...
Sen. Wyden questions Pfizer over tax rate as part of ongoing investigation
Endpoints News· 3 days agoSenate Finance Chair Ron Wyden (D-OR) is pressing Pfizer over its tax practices as part of his investigation into how large pharma companies use subsidiaries in other countries ...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 7 hours agoUnlike the COVID-19 pandemic, when the U.S...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 24 hours agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company announced it was pulling the vaccine ...
1 Top Dividend Stock to Load Up On Now
The Motley Fool via AOL· 2 days agoThey are the bedrock of a portfolio designed for the long haul, offering a balance of stability and growth potential. One healthcare giant stands out In...
3 Biotech Stocks to Buy on the Dip: May 2024
InvestorPlace· 1 day agoDespite their exciting growth potential and undeniable rewards, investors have been selling these stocks, causing a slight dip in price. Pfizer (NYSE:PFE) is a giant in biopharma ...
Time to Pounce: 2 Ultra-High-Yield S&P 500 Dividend Stocks That Are Screaming Buys Right Now
Motley Fool via Yahoo Finance· 3 days agoTwo of these ultra-high-yield S&P 500 dividend stocks are nothing short of screaming buys right now....
